Ruihe Capital
VC Fund
Ruihe Capital is an investment firm.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries Ruihe Capital invests in
Stages Ruihe Capital invests in
Countries Ruihe Capital invests in
Investment Focus
Industry
- Pharmaceutical 7 (35%)
- Medical 5 (25%)
- Biotechnology 4 (20%)
- Biopharma 3 (15%)
- Health Care 3 (15%)
Stage
- Series A 7 (35%)
- Series B 3 (15%)
- Venture - Series Unknown 3 (15%)
- Seed 2 (10%)
- Series D 2 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Leming Pharmaceuticals
|
Le Ming Pharmaceuticals is a pharmaceutical enterprise focusing on R&D, production and sales of innovative pharmaceutical preparation. | $13.8M / Venture - Series Unknown / Jun 07, 2024 | |
Xinyue
|
Yuejing Network Technology Co., Ltd. is a digital video assistant platform that cuts in the communication and review links in the video production stream, helping to achieve multi-platform preview of video demos in video production and convenient review comments and video storage. sort out. With the subsequent connection of external hardware, theuser can realize the real-time synchronization of the video data captured in the camera to the new cloud server, and later can synchronize production and storage sharing through the new reading. | $1.4M / Series A / May 11, 2024 | |
AffectOR MedTech
|
AffectOR MedTech is a medical technology company that specializes in cardiac electrophysiology and energy surgical treatment. | Seed / Nov 06, 2023 | |
Nalinway Nano Technology
|
Nalinway Nano Technology is a research center. They provide products that include the products world, nano slurry, modified masterbatch, and ceramic coating. They offer services for film, sheet, film, injection molding, spinning, and polymerization. | $13.7M / Series D / Nov 03, 2023 | |
Yihe Pharmaceutical
|
Yihe Pharmaceutical is a technology innovation company that focuses on inhalation preparations, inhalation devices, and supporting equipment. | $6.8M / Series A / Oct 16, 2023 | |
LEADRIVE
|
LEADRIVE is a technology company that focuses on the research and development, production, and sales of new energy vehicle drive solutions and high-performance domestic power semiconductor modules. The company is developing a variety of high-performance motor controllers and self-developed power modules for new energy vehicles, which have wondomestic and foreign first-line passenger cars more than 10 models of OEMs and Tier-1 suppliers have been mass-produced and designated, and OEM certification progress for silicon carbide modules and electronic controls is in progress.LEADRIVE is also constantly investing and innovating in the field of new energy equipment such as wind energy, solar energy, and energy storage, and has taken the lead in realizing the localization of power semiconductor modules. LEADRIVE and Japan Rohm Semiconductor have established a joint laboratory to complete the iterative development of a variety of silicon carbide modules and realized simulation, testing, and efficiency from the device, and electronic control, to vehicle-level, promote. | $82.3M / Series D / Oct 09, 2023 | |
Adlai Nortye
|
Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with its R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, it has built a global pipeline through collaborations and internal discoveries with more than 10 drug candidates indevelopment. | $40M / Post-IPO Equity / Sep 29, 2023 | |
Kangpu Biopharmaceuticals, Ltd.
|
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®. | $13.7M / Series B / Aug 30, 2023 | |
Furbulous
|
Furbulous is an online retailer that specializes in pet supplies and accessories for dogs and cats. They provide self-cleaning and packed cat litter boxes. They sell glaring litter, furbulous boxes, deodorant bars, trash bag boxes, fruity vibes nail clippers, pet bath brushes, cat litter boxes, and pet brushes. | Angel / Aug 23, 2023 | |
|
Leming Pharmaceuticals
|
Le Ming Pharmaceuticals is a pharmaceutical enterprise focusing on R&D, production and sales of innovative pharmaceutical preparation. | Series A / Apr 14, 2023 | |
| See all 20 investments → | |||
Co-Investors
Lenovo Capital and Incubator Group (LCIG)
2 deals together
Anker Innovations
1 deal together
Beedie School of Business at Simon Fraser University
1 deal together
C Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ruihe Capital invest in?
Ruihe Capital invests primarily in Pharmaceutical, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 20 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ruihe Capital last invest?
The most recent investment recorded for Ruihe Capital closed in Jun 2024. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
